Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SLXP

Salix Pharmaceuticals (SLXP) Stock Price, News & Analysis

Salix Pharmaceuticals logo

About Salix Pharmaceuticals Stock (NASDAQ:SLXP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
4.96 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SLXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Salix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SLXP Stock News Headlines

Pharmaceuticals News
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Why Salix Pharmaceuticals (SLXP) Stock Is Gaining Today
Why Salix Pharmaceuticals (SLXP) Stock Is Soaring Today
Why Salix Pharmaceuticals (SLXP) Stock Is Surging Today
See More Headlines

SLXP Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Salix Pharmaceuticals investors own include Allergan (AGN), Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Baidu (BIDU), Capri (CPRI), Intercept Pharmaceuticals (ICPT) and Visa (V).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:SLXP
CIK
1009356
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:SLXP) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners